Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Surveillance of Development and Progression of Hepatocellular Carcinoma

NCT05286099 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT05286099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05286099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Surveillance of Development and Progression of Hepatocellular Carcinoma
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 15, 2022
Completion date
December 31, 2023
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma